High-Throughput Epitope Binning Assays on Label-Free Array-Based Biosensors Can Yield Exquisite Epitope Discrimination That Facilitates the Selection of Monoclonal Antibodies with Functional Activity

Here, we demonstrate how array-based label-free biosensors can be applied to the multiplexed interaction analysis of large panels of analyte/ligand pairs, such as the epitope binning of monoclonal antibodies (mAbs). In this application, the larger the number of mAbs that are analyzed for cross-blocking in a pairwise and combinatorial manner against their specific antigen, the higher the probability of discriminating their epitopes. Since cross-blocking of two mAbs is necessary but not sufficient for them to bind an identical epitope, high-resolution epitope binning analysis determined by high-throughput experiments can enable the identification of mAbs with similar but unique epitopes. We demonstrate that a mAb's epitope and functional activity are correlated, thereby strengthening the relevance of epitope binning data to the discovery of therapeutic mAbs. We evaluated two state-of-the-art label-free biosensors that enable the parallel analysis of 96 unique analyte/ligand interactions and nearly ten thousand total interactions per unattended run. The IBIS-MX96 is a microarray-based surface plasmon resonance imager (SPRi) integrated with continuous flow microspotting technology whereas the Octet-HTX is equipped with disposable fiber optic sensors that use biolayer interferometry (BLI) detection. We compared their throughput, versatility, ease of sample preparation, and sample consumption in the context of epitope binning assays. We conclude that the main advantages of the SPRi technology are its exceptionally low sample consumption, facile sample preparation, and unparalleled unattended throughput. In contrast, the BLI technology is highly flexible because it allows for the simultaneous interaction analysis of 96 independent analyte/ligand pairs, ad hoc sensor replacement and on-line reloading of an analyte- or ligand-array. Thus, the complementary use of these two platforms can expedite applications that are relevant to the discovery of therapeutic mAbs, depending upon the sample availability, and the number and diversity of the interactions being studied.

[1]  S. Meeks,et al.  The diversity of the immune response to the A2 domain of human factor VIII. , 2013, Blood.

[2]  C. Klein,et al.  Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties , 2013, mAbs.

[3]  P. S. Andersen,et al.  Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. , 2012, Blood.

[4]  A. Rajpal,et al.  Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity. , 2012, Journal of immunological methods.

[5]  M. Shokrgozar,et al.  Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells. , 2012, Experimental cell research.

[6]  K.,et al.  Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression. , 2012, Journal of molecular biology.

[7]  Hong Yan Song,et al.  Comparative study of random and oriented antibody immobilization as measured by dual polarization interferometry and surface plasmon resonance spectroscopy. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[8]  P. S. Andersen,et al.  Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor , 2011, mAbs.

[9]  B Ribba,et al.  Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth , 2011, Oncogene.

[10]  A. Rajpal,et al.  Expanding the ProteOn XPR36 biosensor into a 36-ligand array expedites protein interaction analysis. , 2011, Analytical biochemistry.

[11]  James E Crowe,et al.  Specificity for human hemoglobin enhances Staphylococcus aureus infection. , 2010, Cell host & microbe.

[12]  Vasant Honavar,et al.  Recent advances in B-cell epitope prediction methods , 2010, Immunome research.

[13]  J. Pons,et al.  Exploring blocking assays using Octet, ProteOn, and Biacore biosensors. , 2009, Analytical biochemistry.

[14]  Mark A. Eddings,et al.  Improved continuous-flow print head for micro-array deposition. , 2008, Analytical biochemistry.

[15]  E. Riise,et al.  Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. , 2008, The Journal of allergy and clinical immunology.

[16]  A. Palmer,et al.  Preparation of ultrapure bovine and human hemoglobin by anion exchange chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  Rebecca L Rich,et al.  Higher-throughput, label-free, real-time molecular interaction analysis. , 2007, Analytical biochemistry.

[18]  Eric P. Skaar,et al.  Staphylococcus aureus IsdB Is a Hemoglobin Receptor Required for Heme Iron Utilization , 2006, Journal of bacteriology.

[19]  Christiana N. Fogg,et al.  Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene. , 2005, Virology.

[20]  R. Eisenberg,et al.  Localization of a Binding Site for Herpes Simplex Virus Glycoprotein D on Herpesvirus Entry Mediator C by Using Antireceptor Monoclonal Antibodies , 2000, Journal of Virology.

[21]  P. François,et al.  Identification of the ligand‐binding domain of the surface‐located fibrinogen receptor (clumping factor) of Staphylococcus aureus , 1995, Molecular microbiology.

[22]  B. Zimmermann,et al.  Direct optical detection of protein-ligand interactions. , 2005, Methods in molecular biology.